Abselion is establishing a U.S. subsidiary at The Engine in Cambridge, Massachusetts. The life sciences technology company, which is based in Cambridge, UK, focuses on simplification of biomolecule quantification. The Engine is an incubator, accelerator, and strategic hub built by the Massachusetts Institute of Technology. Abselion says the new location strengthens the company’s presence in the life sciences ecosystem in North America. It provides a formal base, according to Abselion, for mor...